本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Praxis Precision Medicines, Inc.

312.90
-17.6500-5.34%
盤後314.001.10+0.35%19:57 EDT
成交量:20.57萬
成交額:6,503.87萬
市值:87.15億
市盈率:-24.32
高:333.06
開:330.42
低:311.98
收:330.55
52周最高:392.70
52周最低:40.12
股本:2,785.08萬
流通股本:2,407.65萬
量比:0.73
換手率:0.85%
股息:- -
股息率:- -
每股收益(TTM):-12.8634
每股收益(LYR):-13.4758
淨資產收益率:-38.86%
總資產收益率:-25.65%
市淨率:6.50
市盈率(LYR):-23.22

資料載入中...

2024/10/15

重要事件披露

Form 8-K - Current report
2024/09/23

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/09/03

重要事件披露

Form 8-K - Current report
2024/08/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/13

重要事件披露

Form 8-K - Current report
2024/07/01

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/06/10

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/06/06

重要事件披露

Form 8-K - Current report
2024/05/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/13

重要事件披露

Form 8-K - Current report
2024/03/29

重要事件披露

Form 8-K - Current report
2024/03/26

重要事件披露

Form 8-K - Current report
2024/03/09

SEC問詢函

Form CORRESP - Correspondence
2024/03/05

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/05

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/05

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]